INCIDENCE OF ENDOPHTHALMITIS AFTER INTRA-OPERATIVE MOXIFLOXACIN INJECTION IN THE CAPSULAR BAG, BEHIND THE INTRA OCULAR LENS, IN PHACOEMULSIFICATION. A RETROSPECTIVE STUDY

Y., Mostafa,; P., Sameh,; T., Altak,; A., Marrie,

doi:10.21608/ejco.2022.280977

INCIDENCE OF ENDOPHTHALMITIS AFTER INTRA-OPERATIVE MOXIFLOXACIN INJECTION IN THE CAPSULAR BAG, BEHIND THE INTRA OCULAR LENS, IN PHACOEMULSIFICATION. A RETROSPECTIVE STUDY

Document Type : Original articles: include clinical trials, interventional research, Basic researches and clinically relevant laboratory investigations

Authors

¹ Ophthalmology dept., Faculty of Medicine, Cairo, Univ., Egypt

² Ophthalmology dept., Faculty of Medicine, Cairo, Univ., Egypt,

³ Sheikh Khalifa Medical City - Ajman (SKMCA), UAE

10.21608/ejco.2022.280977

Abstract

Purpose: to evaluate the efficacy and safety of intracapsular moxifloxacin injection at the end
of phacoemulsification as a prophylactic measure against early and late endophthalmitis.
Setting: private eye center, eye Care, Cairo, Egypt. Methods: This is a retrospective clinical
registry-based study. Data was collected from patients who had phacoemulsification within
the capsular bag injection of moxifloxacin at the end of surgery. 0.2 ml of moxifloxacin 0.5%
ophthalmic solution was injected into the bag by placing the tip of the cannula under the
capsulorhexis edge and directing the drug behind the IOL. Results: Data were collected from
EMR for 10919 eyes, that underwent phacoemulsification and in the bag moxifloxacin injection
between January 2015 and August 2022, 4 cases of early endophthalmitis were reported with an
incidence of 0.03%, no cases of late-endophthalmitis, and no cases of toxicity. Conclusion:
Intracapsular moxifloxacin injection at the end of phacoemulsification is a safe effective
prophylactic measure against endophthalmitis.

Keywords